©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Apr 14, 2017; 23(14): 2483-2492
Published online Apr 14, 2017. doi: 10.3748/wjg.v23.i14.2483
Published online Apr 14, 2017. doi: 10.3748/wjg.v23.i14.2483
Potential role of nutraceutical compounds in inflammatory bowel disease
Tiziana Larussa, Maria Imeneo, Francesco Luzza, Department of Health Sciences, University of Catanzaro “Magna Graecia”, Viale Europa, 88100 Catanzaro, Italy
Author contributions: Larussa T performed the majority of the writing, prepared the figures and tables; Imeneo M critically discussed the data and writing; and Luzza F designed the outline and coordinated the writing of the paper.
Conflict-of-interest statement: Authors declare no conflict of interest related to this publication.
Correspondence to: Francesco Luzza, MD, Professor, Department of Health Sciences, University of Catanzaro “Magna Graecia”, Viale Europa, 88100 Catanzaro, Italy. luzza@unicz.it
Telephone: +39-961-3697113 Fax: +39-961-3697164
Received: February 6, 2017
Peer-review started: February 7, 2017
First decision: February 23, 2017
Revised: March 8, 2017
Accepted: March 20, 2017
Article in press: March 20, 2017
Published online: April 14, 2017
Processing time: 66 Days and 21.9 Hours
Peer-review started: February 7, 2017
First decision: February 23, 2017
Revised: March 8, 2017
Accepted: March 20, 2017
Article in press: March 20, 2017
Published online: April 14, 2017
Processing time: 66 Days and 21.9 Hours
Core Tip
Core tip: Current therapies for inflammatory bowel diseases (IBD) include aminosalicylates, azathioprine, corticosteroids and recently clinical management with biologic agents has been implemented. However, safety issue are emerging along with concern about the high cost of these new drugs. Nutraceuticals is a broad term used to describe any product derived from food sources, such as herbal products or vitamins, with extra health benefits beyond the basic nutritional value. Despite few clinical trials in IBD patients, nutraceuticals are generally accepted as safer alternative/supplementation to conventional therapy and the available data support their high potential for therapeutic use in human IBD.